Insider Trading & Ownership - NEWHALL CHARLES W III

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NEWHALL CHARLES W III
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-11
Sale
2024-11-12
4:15 pm
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
10,700$36.24$387,768130,275
(Direct)
View
2023-11-16
Sale
2023-11-20
5:00 pm
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
2,500$28.01$70,025117,089
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-11
Exercise
2024-11-12
4:15 pm
2016-03-03
2025-03-03
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
20,000$0130,275
(Direct)
View
2024-11-11
Exercise
2024-11-12
4:15 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
20,000$9.13130,275
(Direct)
View
2024-02-23
Option Award
2024-02-27
5:04 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
3,886$0120,975
(Direct)
View
2024-02-23
Disposition
2024-02-27
5:04 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
3,886$0120,975
(Direct)
View
2024-02-22
Option Award
2024-02-26
5:02 pm
N/A
2034-02-22
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
13,621$0130,710
(Direct)
View
2023-11-16
Exercise
2023-11-20
5:00 pm
2015-01-21
2024-01-21
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
7,457$0117,089
(Direct)
View
2023-11-16
Exercise
2023-11-20
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
7,457$9.24117,089
(Direct)
View
2023-02-23
Option Award
2023-02-27
5:02 pm
N/A
2033-02-23
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
10,179$0122,311
(Direct)
View
2023-02-22
Option Award
2023-02-24
5:08 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
3,882$0112,132
(Direct)
View
2023-02-22
Disposition
2023-02-24
5:08 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
3,882$0112,132
(Direct)
View
2018-04-17
Ownership
2023-02-08
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
2,203$0108,250
(Direct)
View
2022-12-28
Exercise
2022-12-30
5:01 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
8,722$7.9110,453
(Direct)
View
2022-12-28
Exercise
2022-12-30
5:01 pm
2014-02-05
2023-02-05
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
8,722$0110,453
(Direct)
View
2022-02-22
Option Award
2022-02-24
9:23 pm
2023-02-22
2032-02-22
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
10,729$0112,460
(Direct)
View
2022-02-19
Option Award
2022-02-23
4:20 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
4,222$0101,731
(Direct)
View
2022-02-19
Disposition
2022-02-23
4:20 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
4,222$0101,731
(Direct)
View
2021-02-19
Option Award
2021-02-23
6:46 pm
2022-02-19
2031-02-19
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
11,587$0109,096
(Direct)
View
2020-02-21
Option Award
2020-02-25
5:59 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
5,211$23.99106,814
(Direct)
View
2020-02-21
Option Award
2020-02-25
5:59 pm
2021-02-21
2030-02-21
SUPERNUS PHARMACEUTICALS INC.SUPNNEWHALL CHARLES W III
Director
9,305$0106,814
(Direct)
View